Results 121 to 130 of about 12,338 (187)
Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1. [PDF]
Mol TherTomassy GS +20 more
europepmc +1 more source
Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1). [PDF]
ChemMedChemRichagneux C, Granzhan A.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Neurologic Clinics, 1988
Myotonic dystrophy is an autosomal dominant disorder that results in skeletal muscle weakness and wasting, myotonia, and numerous nonmuscular manifestations including frontal balding, cataracts, gonadal dysfunction, cardiac conduction abnormalities, respiratory insufficiency, and hypersomnolence.
R F, Jozefowicz, R C, Griggs
openaire +2 more sources
Myotonic dystrophy is an autosomal dominant disorder that results in skeletal muscle weakness and wasting, myotonia, and numerous nonmuscular manifestations including frontal balding, cataracts, gonadal dysfunction, cardiac conduction abnormalities, respiratory insufficiency, and hypersomnolence.
R F, Jozefowicz, R C, Griggs
openaire +2 more sources
Continuum, 2022
Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) are genetic disorders affecting skeletal and smooth muscle, heart, brain, eyes, and other organs. The multisystem involvement and disease variability of myotonic dystrophy have presented challenges for clinical care and research.
openaire +2 more sources
Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) are genetic disorders affecting skeletal and smooth muscle, heart, brain, eyes, and other organs. The multisystem involvement and disease variability of myotonic dystrophy have presented challenges for clinical care and research.
openaire +2 more sources
Myotonic Dystrophy and Myotonic Dystrophy Protein Kinase
Progress in Histochemistry and Cytochemistry, 2000Myotonic dystrophy protein kinase (DMPK) was designated as a gene responsible for myotonic dystrophy (DM) on chromosome 19, because the gene product has extensive homology to protein kinase catalytic domains. DM is the most common disease with multisystem disorders among muscular dystrophies.
H, Ueda, S, Ohno, T, Kobayashi
openaire +2 more sources
Medical Hypotheses, 1985
Myotonic dystrophy (MYD) has been localized to chromosome 19. Like other hereditary diseases with a genetic locus assigned to chromosome 19, MYD is a genetically inherited autosomal dominant disease. It is speculated that such a genetic pattern may express the characteristics of chromosome 19.
openaire +2 more sources
Myotonic dystrophy (MYD) has been localized to chromosome 19. Like other hereditary diseases with a genetic locus assigned to chromosome 19, MYD is a genetically inherited autosomal dominant disease. It is speculated that such a genetic pattern may express the characteristics of chromosome 19.
openaire +2 more sources